Navigation Links
DrugRisk Adds New Pancreatic Cancer Warning for Diabetes Drug Januvia
Date:5/2/2013

Los Angeles, CA (PRWEB) May 02, 2013

The diabetes drug safety advocates at DrugRisk.com are announcing new information on the site for those taking the medication Januvia. A recent study suggests the drug may have higher occurrence rates of pancreatitis and pancreatic cancer than traditional pills****.

DrugRisk was created to improve patient safety by providing the latest warnings, recalls, studies and legal news to those taking popular prescription drugs. Visitors can see if others are experiencing similar side effects and decide if they need legal advice.

Januvia is a once-a-day pill introduced in 2006 to help those with type-2 diabetes control blood sugar. It has become Merck’s best-selling drug, with sales of over $4 billion last year*.

However, a 2011 study from UCLA indicated the drug could increase the risk of pancreatic cancer by 272% and thyroid cancer by 148%**. The Journal for the American Medical Association also recently warned Januvia could double the risk of pancreatitis, a major risk factor for pancreatic cancer***.

Now, DrugRisk has added a new study by the Institute for Safe Medication Practices, which found in an analysis of FDA reports that patients were 20.8 times as likely to report pancreatitis or pre-cancerous growth from Januvia than from traditional diabetes treatment like metformin****.

Due to the rising number of patients filing a Januvia lawsuit alleging cancer, lawyers have requested that cases be consolidated to a special federal multi-district court in California. (In Re: Incretins Products Liability, Sales and Marketing Litigation, MDL 2452, United States Judicial Panel on Multidistrict Litigation).

Anyone affected by cancer after taking Januvia is encouraged to speak with a lawyer about their legal options. However, due to the specialized nature of federal drug injury cases, DrugRisk only recommends lawyers who have already handled Januvia lawsuits.

For more information on the research, Januvia side effects and litigation news related to Januvia and other drugs, or to speak with a lawyer, visit http://www.DrugRisk.com.

*Bloomberg News, 2/25/13; bloomberg.com/news/2013-02-25/merck-bristol-diabetes-drugs-linked-to-pancreatitis-risk.html
**Gastroenterology, July, 2011; ctsi.ucla.edu/education/files/publicview/training/docs/FDA-analysis.pdf
***Journal of the American Medical Association, 2/25/13; archinte.jamanetwork.com/article.aspx?articleid=1656537
****Institute for Safe Medication Practices, 4/18/13; ismp.org/QuarterWatch/pdfs/2012Q3.pdf

Read the full story at http://www.prweb.com/releases/januvia-lawsuit-cancer/side-effects-lawsuits/prweb10671536.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. DrugRisks News Update: Bayer Loses Yaz Patent as Blood Clot Settlements Continue
2. DrugRisk Update: Court Asks for Pradaxa Lawsuit Test Cases
3. DrugRisks Adds Update From Court Ordering Mediation of Stryker Hip Lawsuits
4. DrugRisk Announces Launch of Byetta Cancer Resource Center
5. DrugRisks Update: Federal Court Schedules First Mirena Lawsuit Hearing
6. DrugRisk Announces Addition of Januvia Cancer Resource Center
7. DrugRisks Legal Update: Jury to Decide Actos Cancer Trial This Week
8. DrugRisks Update: Doctor Testifies Actos Main Cause of Bladder Cancer in Trial
9. DrugRisk Announces Launch of DePuy Hip Resource Center
10. DrugRisk Update: Mirena Maker Asks to Keep Lawsuits With Local Court, Judge
11. DrugRisks Adds Study Showing Pradaxa Viral Infection Risk
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... Ohio (PRWEB) , ... March 28, 2017 , ... Columbus ... was selected as one of few medical professionals in the country to sit on ... Founder of Juvly Aesthetics, in just 2 years Dr. Harper helped propel the clinic ...
(Date:3/28/2017)... , ... March 28, 2017 , ... ... of SkyLex Advanced Surgical, Inc. is thrilled to offer the recently FDA-approved Obalon ... and this procedure adds to SkyLex Advanced Surgical’s already comprehensive list of ...
(Date:3/28/2017)... (PRWEB) , ... March 28, 2017 , ... With expansion ... Marshallville, Georgia, in early March. , The seed processing plant opened in Marshallville in ... since 2016. The new office allows opportunity for transition of Patten Seed operations to ...
(Date:3/28/2017)... , ... March 28, 2017 , ... Thank you to ... on February 8-10. , This event was exclusive to providers and offered an ... The meeting took place at the Manchester Grand Hyatt where attendees gathered for a ...
(Date:3/28/2017)... ... 2017 , ... Bacteria and fungi are probably not the first ingredients that come to mind ... right microorganisms in your diet can actually improve health outcomes. And the good news is ... topic of a new peer-reviewed paper led by Maria Marco, Ph.D. , ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)...  A new survey from the American ... Bidding Program (CBP) significantly reduced beneficiary choice and access ... choice forces beneficiaries to switch to unfamiliar or unsuitable ... AADE,s survey is the latest in a ... out the inherent problems with the CBP. Last year, ...
(Date:3/27/2017)... YORK , March 27, 2017 FinancialBuzz.com News ... According to a new ... North America , grew 34 percent to $6.7 billion and ... rate of (CAGR) over the next five years, from $6.7 billion in ... of Americans that will be able to purchase cannabis without a doctor,s ...
(Date:3/27/2017)... March 27, 2017   Pulmatrix, Inc . (NASDAQ: PULM), ... address serious pulmonary diseases, today announced that it has added ... fibrosis and asthma to its Scientific Advisory Board . ... Richard B. Moss , MD, former chief of the ... Cystic Fibrosis Center at Stanford University, and ...
Breaking Medicine Technology: